Please assess the completion status of the following clinical trial:

Trial Title: TPI Medication Comparison - Ketorolac, Lidocaine, or Dexamethasone

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Men or women age 18 or over~2. At least one active trigger point~Exclusion Criteria:~1. Allergy or contraindication to any NSAID, CS, or local anesthetic~2. Receiving anticoagulant medication~3. History of bleeding disorder~4. Pregnant or breast feeding women~5. Gastrointestinal ulceration~6. Pre-existing renal disease~7. Pre-existing congestive heart failure~8. Diabetes mellitus~9. Prior myocardial infarction or stroke~10. Fibromyalgia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: t

Study Arms:
- Ketorolac (Type: EXPERIMENTAL): Participants may be randomized to receive Ketorolac for their TPI.
- Lidocaine (Type: EXPERIMENTAL): Participants may be randomized to receive Lidocaine for their TPI.
- Dexamethasone (Type: EXPERIMENTAL): Participants may be randomized to receive Dexamethasone for their TPI.

Based on this trial design, predict the completion outcome and termination type (if applicable).